)
Edge26 Jun 2026
The Universal Language: Inventing the Barcode
How lines in the sand on a Miami beach became the most scanned symbol in human history, and why it took decades for anyone to care.
Rallybio
Rallybio (RLYB) investor relations material
Rallybio has been acquired
Rallybio M&A announcement summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.M&A announcement summary1 Jun, 2026
Deal rationale and strategic fit
The merger aims to create a leading oncology-focused biotech with a robust pipeline of next-generation therapies, leveraging expertise in small molecules and antibody-drug conjugates for cancer treatment.
The combined entity, to operate as Avenzo Therapeutics, will focus on addressing significant unmet needs in oncology, with exclusive rights outside Greater China.
Leadership team with deep oncology drug development experience will guide the new company.
Financial terms and conditions
The transaction includes a $215 million oversubscribed private placement financing, funding operations into late 2028.
Pre-transaction Rallybio equityholders will own approximately 2.8% and Avenzo equityholders (including new investors) about 97.2% of the combined company.
Rallybio will distribute nearly all pre-closing net cash to its stockholders and issue contingent value rights (CVRs) tied to legacy asset proceeds.
Synergies and expected cost savings
The merger brings together teams with deep oncology drug development expertise, aiming to efficiently advance four clinical-stage programs and support multiple clinical milestones and data readouts in 2027 and 2028.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Rallybio
- Net loss improved to $9.0 million in 2025 amid a pending merger, asset sale, and cost reductions.RLYB
Q4 202516 Mar 2026 - Merger forms a TCE therapeutics leader with $700M cash and a broad autoimmune disease pipeline.RLYBM&A announcement2 Mar 2026
- Majority approved a reverse stock split amendment; final results to be filed in Form 8-K.RLYBEGM 20262 Feb 2026
- Best-in-class efficacy, improved tolerability, and strong market demand drive $6B opportunity.RLYBStatus Update12 Jan 2026
- Rare disease pipeline advances, with key clinical milestones and new data expected in 2024.RLYB7th Annual Evercore HealthCONx Conference11 Jan 2026
- Shareholders will vote on a reverse stock split to help maintain Nasdaq listing compliance.RLYBProxy Filing2 Jan 2026
- Lead rare disease programs advance with key data readouts and market expansion in 2024.RLYBTD Cowen 45th Annual Healthcare Conference26 Dec 2025
- Shareholders will vote on a reverse stock split to maintain Nasdaq listing and enhance liquidity.RLYBProxy Filing23 Dec 2025
- Annual meeting to elect directors, ratify auditor, and review governance, compensation, and ESG.RLYBProxy Filing2 Dec 2025
Rallybio
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage